Mass Tort News

Latest Mass Tort Litigation News

Current Litigation

Nuedexta: Drug Being Pushed “Off-Label” On Elderly In Nursing Homes = $116 Million Settlement

Avatar Current Litigation January 7, 2020

Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year  by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe Off-label use is when a company offers and markets a drug for reasons other than what it was initially approved for by the FDA The vast majority of the “off-label” related payments to nursing homes are coming straight from the federal government Both civil and criminal actions are often...

JUUL: How Big Tobacco bought into a company that killed teens for profit!

Avatar Current Litigation , JUUL December 27, 2019

The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s principal advertising themes have been closely aligned with that of traditional tobacco advertising” Why is Juul so popular among teens Although Juul demands age verification upon navigating to its website and holds a firm stance...

Breast implant

FDA FINALLY MOVING ON BREAST IMPLANTS: Once again lagging behind the world in healthcare oversight

Avatar Breast Implants , Current Litigation October 25, 2019

(MASS TORT NEWS) US health officials are now finally taking an assertive position regarding women getting breast implants by stating that stronger warnings and more details about the possible risks and complications including links to cancer Why has there been a multi-year FDA delay on this in the USA The Food and Drug Administration said that manufacturers should add a warning highlighted by a “black box warning” - the most serious type – to be provided to women receiving or considering implants The primary makers of breast implants approved for use in the United States include: Allergan,...

Why Does the FDA Ignore “Off-Label” Drug Marketing While Thousands Die Every Year?

Avatar Current Litigation , Opioid Crisis October 19, 2019

Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS)  Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses They also engaged in a parallel strategy, where they were influencing the FDA and other policy making agencies behind the scenes in Washington DC Big Pharma was paying millions to lobbyists, making campaign donations and generally buying influence as they...